n-acetylaspartic acid has been researched along with Parkinsonian Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Fu, W; Sun, X; Wang, X; Zheng, Z; Zhuang, W | 1 |
| Bienaimée, MJ; Delmaire, C; Galanaud, D; Gaymard, B; Hartmann, A; Jodoin, N; Lannuzel, A; Lehéricy, S; Roze, E; Vidailhet, M | 1 |
| Hadjiconstantinou, M; Neff, NH; Podell, M; Smith, MA | 1 |
| Benner, EJ; Boska, MD; Destache, CJ; Gendelman, HE; Lewis, TB; Mosley, RL; Nelson, JA; Uberti, M | 1 |
| Cantú-Martínez, L; Flores, Lde L; González, HC; Martínez, HR; Onofre-Castillo, J; Villarreal, HJ | 1 |
| Blezer, EL; Jongsma, MJ; Olivier, B; Philippens, IH; van Vliet, SA; van Vlieta, SA; Vanwersch, RA | 1 |
| de Mari, M; Federico, F; Ferrari, E; Lamberti, P; Lucivero, V; Mezzapesa, DM; Petruzzellis, M; Simone, IL | 1 |
7 other study(ies) available for n-acetylaspartic acid and Parkinsonian Disorders
| Article | Year |
|---|---|
Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy.
Topics: Animals; Aspartic Acid; Cell Differentiation; Cell Survival; Choline; Corpus Striatum; Creatine; Disease Models, Animal; Female; Magnetic Resonance Spectroscopy; Male; Mesenchymal Stem Cell Transplantation; Microtubule-Associated Proteins; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Time Factors; Tyrosine 3-Monooxygenase | 2013 |
Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
Topics: Aged; Aspartic Acid; Brain; Case-Control Studies; Cognition Disorders; Creatinine; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging; Female; Guadeloupe; Hallucinations; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Parkinsonian Disorders; Supranuclear Palsy, Progressive | 2010 |
Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Brain; Cats; Choline; Corpus Striatum; Creatine; Disease Models, Animal; Disease Progression; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Neurologic Examination; Pargyline; Parkinsonian Disorders; Predictive Value of Tests; Protons; Tyrosine 3-Monooxygenase | 2003 |
Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease.
Topics: Adoptive Transfer; Animals; Aspartic Acid; Cell Count; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Glatiramer Acetate; Immunization; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mice; Microglia; MPTP Poisoning; Myelin Basic Protein; Nerve Degeneration; Nerve Tissue Proteins; Ovalbumin; Parkinsonian Disorders; Peptides; Substantia Nigra; T-Lymphocyte Subsets; Tyrosine 3-Monooxygenase | 2005 |
Epilepsy, parkinsonism, and neuroleptic malignant syndrome in a child.
Topics: Anticonvulsants; Antiparkinson Agents; Aspartic Acid; Basal Ganglia; Benzothiazoles; Carbamazepine; Child; Electroencephalography; Epilepsy; Epilepsy, Complex Partial; Female; Humans; Magnetic Resonance Spectroscopy; Neuroleptic Malignant Syndrome; Parkinsonian Disorders; Phenytoin; Pramipexole; Time | 2006 |
Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Benzhydryl Compounds; Biomarkers; Brain; Callithrix; Disease Models, Animal; Dopamine; Drug Administration Schedule; Immunohistochemistry; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Modafinil; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Phosphocreatine; Predictive Value of Tests; Reproducibility of Results; Substantia Nigra; Treatment Outcome; Tyrosine 3-Monooxygenase | 2008 |
Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes.
Topics: Adult; Aged; Aspartic Acid; Brain; Choline; Creatine; Diagnosis, Differential; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Phosphocreatine; Supranuclear Palsy, Progressive | 1999 |